Daniel Kim, MD
Neurological Surgery · Houston, TXNPI 1275542516
Payments from drug & device makers
Across 173 payments — averaging $477.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$65K
- Intuitive Surgical$8K
- Stryker$4K
- Medtronic$1K
- Boston Scientific$1K
- VB Spine LLC$1K
- plus $2K from 11 others
What the payments were for
- Royalty or licence$65,06079%
- Travel & lodging$2,5923%
- Food & beverage$6,8288%
- Education$7,0008%
- Ownership interest$1,1771%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 29 | $65,060 |
| Intuitive Surgical | 8 | $7,886 |
| Stryker | 61 | $3,846 |
| Medtronic(3 entities) | 19 | $1,474 |
| Boston Scientific | 4 | $1,236 |
| VB Spine LLC | 25 | $1,208 |
| Nevro Corp. | 11 | $897 |
| Globus Medical | 5 | $224 |
| Zimvie Inc. | 2 | $206 |
| Cerapedics Inc. | 1 | $166 |
| Livanova USA, Inc. | 1 | $146 |
| Sanofi | 1 | $112 |
| Pfizer | 1 | $62 |
| EMD Serono, Inc. | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 1 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| BTG International Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPEDIUM$65,060
- Da Vinci Surgical System$7,851
- EVEREST SPINAL SYSTEM$1,935
- GENERAL - THERAPIES$1,080
- INTELLIS ADAPTIVESTIM$663
- Senza$648
- XIA 3$310
- CASCADIA INTERBODY SYSTEM$246
- DUPIXENT$225
- SYNCHROMEDII$197
- OZARK CERVICAL PLATE SYSTEM$174
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$166
- RESTORE$158
- Vyrsa V1$146
- VNS Therapy Symmetry Model 8103 Generator$146
- Mobi-C$129
- NA$126
How this compares
$82,658 in reported general payments places this provider in the 85th percentile of 582 neurological surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 303 | $4,768 |
| Cyclobenzaprine Hcl | 175 | $893 |
| Gabapentin | 67 | $493 |
| Methylprednisolone | 51 | $360 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $342 |
| Meloxicam | 48 | $172 |
| Duloxetine Hcl | 19 | $161 |
| Diclofenac Sodium | 11 | $132 |
| Tramadol Hcl | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Houston
- Daniel CurryHouston$3M
- Homero AnchondoHouston$799K
- Claudio TatsuiHouston$777K
- Arthur DayHouston$746K
- Andrew RoeserHouston$660K
- Peng ChenHouston$550K
- Daniel YoshorHouston$519K
- Paul HolmanHouston$516K
- Nitin TandonHouston$510K
- Nelson MossHouston$501K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.